Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase F1 subunit epsilon pseudogene 2 (ATP5F1EP2) is a human pseudogene related to the mitochondrial ATP synthase F1 complex epsilon subunit. This pseudogene is annotated as lacking protein-coding potential and is predicted, rather than proven, to enable activities seen in functional counterparts, such as hydrolase activity or ATP synthesis participation; it does not encode a functional enzyme or known therapeutic target. In general, pseudogenes like ATP5F1EP2 are not expressed as active proteins and are not involved in recognized biological, therapeutic, or disease processes. Key context and cautions: - ATP5F1EP2 is a pseudogene and should not be confused with ATP5F1E, the actual protein-coding gene for ATP synthase F1 subunit epsilon, which is functional and implicated in mitochondrial energy metabolism and some diseases. - All drug target, biomarker, or therapeutic relevance ascribed to ATP synthase epsilon subunit comes from studies on ATP5F1E not ATP5F1EP2. For functional and clinical details about the ATP synthase epsilon subunit, refer to the protein-coded by ATP5F1E rather than this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase F1 subunit epsilon pseudogene 2 (ATP5F1EP2).